About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
452
By Phase
PHASE2: 3PHASE1: 2
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06545929Lead Sponsor
Study of Sunobinop on Craving in Alcohol Use Disorder
PHASE2Completed
40 participants
Started: Jan 28, 2025 · Completed: Jul 14, 2025
NCT06545916Lead Sponsor
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
PHASE2Recruiting
200 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2026
NCT06024642Lead Sponsor
Study of V117957 in Overactive Bladder Syndrome
PHASE1Completed
51 participants
Started: Jun 30, 2022 · Completed: May 21, 2024
NCT06285214Lead Sponsor
Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome
PHASE1Completed
47 participants
Started: May 26, 2022 · Completed: Jan 28, 2025
NCT04035200Lead Sponsor
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
PHASE2Completed
114 participants
Started: Sep 23, 2019 · Completed: Nov 6, 2020
Locations (1)
Headquarters
Stamford, CT, United States
Map
Loading map...